88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test SINGAPORE , May 28, 2026 /PRNewswire/ -- Gene Solutions , a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the ... 2026-05-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
HEALEY ALS Platform Trial Regimen I expands to 240 participants Highlights: ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines for cancer prevention, screening, treatment, and supportive ... 2026-05-27T Health Care/Hospital Medical/Pharmaceuticals
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit Democratizing metabolomics for researchers worldwide, the new kit brings Metabolon's analytically rigorous, scalable metabolomics into workflows designed for integrated biological insights ... 2026-05-27T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery SHANGHAI , May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, " Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery SHANGHAI , May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV - Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer SHANGHAI , May 27, 2026 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that ... 2026-05-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List HONG KONG , May 27, 2026 /PRNewswire/ -- On 27 May 2026, Fortune China magazine released its 2026 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun ... 2026-05-27T Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities SHANGHAI , May 27, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Drug Product Facility 15 (DP15), ... 2026-05-27T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved